As noted by Cleveland Clinic, parasomnia is a sleep disorder that involves unusual and undesirable physical events or experiences that disrupt sleep. They include sleep terrors, sleepwalking, and even sleep sex and eating. Dr. Anne Marie Morse provided DocWire News with a clearer picture of parasomnias, and how they affect quality of life in people who have them.
Advertisement
It is important to understand the challenges Medicare Advantage plans present for ESRD care.
A blood-based, non-invasive classifier can serve as an optional tool for conventional methods in the detection of NETs.
Kaplan-Meier curves showed that patients with high TBS had significantly decreased OS and increased recurrence rates.
A project led by a researcher from the Dana-Farber Cancer Center is the first to receive the four-year grant of $2.5 million.
Dr. Ajay Singh discusses the reasons why medical students and residents are not choosing to pursue careers in nephrology.
The accuracy of continuous glucose monitoring versus self-monitored blood glucose in hemodialysis patients is not well known.
HERIZON-BTC-01 marks the largest phase IIb clinical trial to date for patients with previously treated HER2-positive disease.
For patients with Schlafen 11-positive ES-SCLC, atezolizumab plus talazoparib showed an PFS improvement after chemotherapy.
DocWire Content Partners
Gain insights from The CardioNerds, a group of cardiology experts who aim to democratize cardiovascular education.
Fundamentals, core concepts, and important management approaches in the field of hematology and oncology
Dr. Chadi Nabhan, a renowned voice in hematology and oncology, tackles a multitude of relevant health care topics.
Drs. Rohit Gosain and Rahul Gosain discuss practice-changing data and standards of oncology care.
Dr. Hady Lichaa is an interventional cardiologist specializing in complex coronary interventions.
Review important issues in the rheumatology space, including lupus, rheumatoid arthritis, and more, from Dr. Maheswaranathan.
Powered by DocWire News
The Latest From GI Oncology Now
A blood-based, non-invasive classifier can serve as an optional tool for conventional methods in the detection of NETs.
Kaplan-Meier curves showed that patients with high TBS had significantly decreased OS and increased recurrence rates.
HERIZON-BTC-01 marks the largest phase IIb clinical trial to date for patients with previously treated HER2-positive disease.
A recent analysis reviewed patient-level data to identify the relationship between pathological response and relapse.
Dr. Kimmie Ng shares the experiences that drive her dedication to seeking improved patient outcomes in GI oncology care.
A recent study compared first-line chemotherapy, as the standard of care for PDAC, with other treatment options.
The Latest From Heme Today
The favorable effects from pharmacologic iron restriction may also be enhanced when used with an erythroid maturation agent.
Analysts advise that CMML that features AML-associated mutations should undergo management approaches typically used for AML.
Expert panel consensus produced a set of genomics-based disease categories from the two systems' morphology-based categories.
Clinicians seek alternatives to biopsy for clinically evaluating bone marrow mutations in cytopenic patients.
A retrospective study's insights help inform timing decisions regarding allogenic HCT in patients with MDS or CMML.
Investigators examined patients' baseline transfusion burdens and erythropoietin levels for correlations with agent response.
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.